Chemkart India Limited (BSE SME)
July 7, 2025 – July 9, 2025
| Price | ₹236 - ₹248 |
| Premium | ₹0 |
|---|---|
| Lot size | 600 |
| Allotment | Jul 10, 2025 |
| Listing | Jul 14, 2025 |
About
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| INDIVIDUAL | 2 | 1200 | 297600 | 1798 |
| sHNI | 3 | 1800 | 446400 | 257 |
| bHNI | 7 | 4200 | 1041600 | 514 |
IPO Reservation
| Investor Category | Shares Offered | No. of Shares |
|---|---|---|
| INDIVIDUAL | 33.41% | 10,78,800 |
| SHNI | 4.78% | 1,54,400 |
| BHNI | 9.56% | 3,08,800 |
| ANCHOR | 28.22% | 9,11,400 |
| QIB | 18.88% | 6,09,600 |
| MARKET MAKER | 5.15% | 1,66,200 |
| Total | 100.00% | 32,29,200 |
IPO Details
| Total Issue Size | 32,29,200 shares (aggregating up to 80.08 Cr) |
| Fresh Issue | 26,00,000 shares (aggregating up to 64.48 Cr) |
| Offer for Sale | 6,29,200 shares (aggregating up to 15.60 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 94,99,000 shares |
| Reserved for Market Maker | 1,66,200 shares |
| Market Maker | Alacrity Securties Limited |
Key Performance Indicator (KPI)
| KPI | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| ROCE | 45.52% | 50.04% | 52.84% |
| EPS (basic) | 25.54 | 15.28 | 8.06 |
| P/E Pre IPO | 9.71 | ||
| P/E Post IPO | 12.37 |
Company Financials In Crores
| Period Ended | Mar-25 | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|---|
| Assets | 86.11 | 53.51 | 37.48 | 24.54 |
| Revenue | 205.46 | 132.83 | 131.69 | 87.43 |
| Profit After Tax | 24.26 | 14.52 | 7.66 | 5.48 |
| Net Worth | 53.29 | 29.01 | 14.5 | 6.84 |
| Reserves and Surplus | 43.79 | 27.66 | 13.14 | 5.48 |
| Total Borrowing | 17.03 | 12.55 | 11.33 | 5.66 |
About Company
Founded in 2015, Chemkart India Limited is a dedicated B2B distributor of premium-quality food and health ingredients. The company serves as a vital link between international ingredient manufacturers and businesses operating in sectors such as health, wellness, sports nutrition, and dietary supplements.
Business Focus
Chemkart focuses on supplying ingredients used in the manufacturing of health supplements, including vitamins, protein powders, sports nutrition products, and functional foods. Its business model is built on the principles of quality assurance, affordability, product diversity, and strong customer relationships that support a more efficient supply chain for clients.
Processing & Facility
The company operates from a state-of-the-art processing unit located in Bhiwandi, Mumbai, spanning 28,259.16 sq. ft. This hygienic facility offers services such as ingredient grinding, blending, labeling, packaging, and sealing, ensuring streamlined handling and delivery of raw materials.
Product Portfolio
- Amino Acids – Crucial for protein synthesis, metabolism, and biological functions.
- Health Supplements – Nutrient-rich blends designed to support overall wellness.
- Herbal Extracts – Plant-based concentrates known for their therapeutic benefits.
- Nucleotides – Functional components that aid in immune support and gut health.
- Proteins – Essential for muscle development, immunity, and general health.
- Sports Nutrition – Specialized ingredients to enhance physical performance and recovery.
- Vitamins – Micronutrients required for essential physiological processes.
Strength
Broad and Diverse Product Portfolio: The company offers a wide range of nutraceutical ingredients across seven major categories including amino acids, proteins, vitamins, herbal extracts, and sports nutrition. This variety allows them to meet the evolving needs of a diverse customer base.
In-House Processing and Warehousing Facility: With a 28,259 sq. ft. facility in Bhiwandi, Mumbai, the company efficiently manages blending, grinding, packaging, and labeling under strict hygiene standards—supported by skilled staff and contract specialists for large-scale operations.
Strong B2B Customer Relationships: Operating in the B2B segment, the company focuses on building long-term, trust-based relationships with clients. This relationship-driven approach enhances customer retention and drives sustainable growth in the nutraceutical sector.
Weakness
No Exclusive Supplier Agreements: The company lacks exclusive contracts with vendors, which may impact the consistency and reliability of raw material supply during high-demand or shortage periods.
High Working Capital Dependency: Maintaining large inventories to meet customer demands can result in elevated working capital requirements, especially during periods of slow sales, potentially straining financial resources.
Reliance on Key Personnel: The business depends heavily on specific individuals for essential functions like market trend analysis and supply chain operations. Loss of such key personnel could disrupt operations and strategic execution.
Lead Manager(s)
Address
4th Floor, K.L. Accolade, 6th Road,
TPS III, Santacruz (East), Mumbai - 400055
Mumbai, Maharashtra, 400055
Phone: +91 9136383828
Email: investors@chemkart.com
Website: https://chemkart.com/